NACDS submitted comments to the State Bureau of Narcotics and Dangerous Drugs Control (OBNDD) on proposed rule changes pertaining to the information that pharmacies are required to report to Oklahoma’s prescription drug monitoring program (PDMP). The letter recommended that the data pharmacies are required to report should be limited to information that is required to be on a controlled substance prescription and/or required to process third party claims. NACDS also commented that costly software changes would be needed for pharmacy dispensing and management computer systems to accommodate the reporting of added data elements.
For more information, contact NACDS’ Mary Staples at 817-442-1155.